HDAC-IN-54

Overview

HDAC-IN-54 is a HDAC inhibitor with an IC 50 of 25 nM against human HDAC1 , 66 nM against HDAC2 , 6.5 nM against HDAC3 , and 281 nM against HDAC6 . HDAC-IN-54 induces acetylation of α-tubulin and histone H3 . HDAC-IN-54 acts synergistically with cisplatin to induce cancer cell apoptosis . HDAC-IN-54 can be used in research related to head and neck cancer , ovarian cancer , and tongue squamous cell carcinoma.

Application

Products | Products > Disease Areas > Urogenital Disease | Products > Disease Areas > Ovarian Cancer | Products > Disease Areas > Urogenital Cancer | Products > Disease Areas > Cancer | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Epigenetics | Products > Signaling Pathways > Cytoskeleton | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > HDAC | Products > Signaling Pathways > Microtubule/Tubulin | Products > Signaling Pathways > Apoptosis

Product Information

• Catalog No.: HY-153514
• CAS No.: 2098896-13-8
• Molecular Formula: C24H32N4O4
• Molecular Weight: 440.54
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source